BACKGROUND AND AIMS: Diet-induced obesity (DIO) is an excellent model for examining human obesity comprising both genotypic and environmental (diet) factors. Decreased responsiveness to peripheral satiety signaling may be responsible for the hyperphagia in this model. In this study, we investigated responses to nutrient-induced satiation in outbred DIO and DIO-resistant (DR) rats fed a high-energy/high-fat (HE/HF) diet as well as intestinal satiety peptide content, intestinal nutrient-responsive receptor abundance and vagal anorectic receptor expression. METHODS: Outbred DIO and DR rats fed a HE/HF diet were tested for short-term feeding responses following nutrient (glucose and intralipid (IL)) gastric loads. Gene and protein expressions of intestinal satiety peptides and fatty acid-responsive receptors were examined from isolated proximal intestinal epithelial cells and cholecystokinin-1 receptor (CCK-1R) and leptin receptor (LepR) mRNA from the nodose ganglia of DIO and DR animals. RESULTS: DIO rats were less responsive to IL-(Po0.05) but not glucose-induced suppression of food intake compared with DR rats. DIO rats exhibited decreased CCK, peptide YY (PYY) and glucagon-like peptide-1 (GLP-1; Po0.05 for each) protein expression compared with DR rats. Also, DIO rats expressed more G-protein-coupled receptor 40 (GPR40; Po0.0001), GPR41 (Po0.001) and GPR120 (Po0.01) relative to DR rats. Finally, there were no differences in mRNA expression for CCK-1R and LepR in the nodose ganglia of DIO and DR rats. CONCLUSIONS: Development of DIO may be partly due to decreased fat-induced satiation through low levels of endogenous satiety peptides, and changes in intestinal nutrient receptors. Keywords: diet adaptation; food intake; intestinal chemosensation
INTRODUCTION
The prevalence of obesity and associated metabolic diseases has risen dramatically in the past 30 years, which can be attributed to an interaction of environment (diet) and genetic factors. Accordingly, polygenetic rodent models of diet-induced obesity (DIO) are excellent models that reflect human obesity. 1 When exposed to a high-energy, high-fat (HE/HF) diet, a sub-population of rats becomes obese (DIO), whereas another remains resistant (DIO resistant (DR)) to obesity. 2 Increased caloric intake and energy efficiency accompanies obesity in the DIO rat, and this has been attributed to deficits in peripheral metabolism, 2 central neural functions, 3 reward behavior 4 and intestinal signaling. 5 Accumulating evidence demonstrates that obesity is often associated with decreased responsiveness to intestinal nutrients in animal models. 6, 7 Thus, it is feasible that blunted inhibitory feedback from the post-oral effects of nutrients and/or high-fat feeding that develops over time may also contribute to the hyperphagia and weight gain in DIO rats.
Decreases in sensitivity to nutrient responses from the gut during HF feeding and obesity may be caused by disruptions or alterations in intestinal peptide content or secretion. Fat is a potent secretagogue of both cholecystokinin (CCK) 8 and glucagon-like peptide-1 (GLP-1), 9 and chronic HF feeding leads to subsequent increases in circulating CCK in humans. 10 However, rodents maintained on a HF diet display decreased plasma peptide YY (PYY) and GLP-1, 11, 12 as well as decreased sensitivity to exogenous gut peptides, such as CCK and GLP-1. 11, 13 Furthermore, most studies show that obese subjects, in general, exhibit decreased postprandial levels of gastrointestinal (GI) peptides such as CCK, 14 GLP-1 15 and PYY 12 compared with lean controls, although with some conflicting results, 16, 17 whereas weight loss following gastric bypass surgery is associated with rapid increases in these peptides. 18 Despite this evidence, it is not known whether DIO rats are less sensitive to GI nutrients, and whether alterations in GI peptides are associated with this decreased sensitivity. Interestingly, genetically selected inbred DIO rats with transmittable obesity are in fact more sensitive to peripheral CCK. 19 This may be because of decreased intestinal or circulating CCK levels leading to enhanced vagal or central anorectic response from exogenous CCK.
Identification of novel intestinal chemosensors that belong to the G-protein-coupled receptor (GPR) family and respond to specific nutrients has revealed possible mechanisms to ameliorate obesity and metabolic abnormalities. Several intestinal GPRs have been identified that are expressed on the luminal membrane of enteroendocrine cells, colocalized with cells expressing peptide hormones, 20 and implicated in the secretion of peptides, 21 intestinal transit 22 and overall energy balance. 23 GPRs are prime candidates for fatty acid-induced gut peptide secretion. For example, GPR40 (ref. 20) and GPR120, 21, 24 which are activated by medium-and long-chain fatty acids, mediate secretion of CCK and GLP-1. On the other hand, GPR41, which is colocalized with PYY in enteroendocrine cells 25 and is activated by short-chain fatty acids, mediates secretion of PYY. 22 Because of these recent findings, and the fact that HF feeding results in altered peptide secretion and subsequent changes in feeding responses, we hypothesized that HE/HF diet feeding and the resultant obese phenotype lead to pronounced changes in nutrient receptor expression and impaired expression of intestinal peptides in DIO animals.
The information from GI signals controlling food intake and energy balance is integrated at the level of vagal afferent neurons. 26 For example, cholecystokinin-1 receptor (CCK-1R) and leptin receptor (LepR) are found on vagal afferents, 27 and mutations in either receptor or their signaling pathways result in hyperphagia and obesity. Furthermore, HF feeding and/or the obese phenotype results in changes in sensitivity of vagal afferents such as decreased sensitivity to CCK 13, 28 and leptin resistance. 29 However, whether changes in vagal afferent receptor expression occur as a function of the obese phenotype during HE/HF feeding is not clear. Therefore, in these studies using outbred DIO rats fed a HE/HF diet, we examined feeding responses after intragastric (IG) nutrient loads as well as gene and protein expressions of gut peptides, and nutrient-responsive GPRs in intestinal epithelium, and anorectic peptide receptor expression in the nodose ganglia.
MATERIALS AND METHODS

Animals and selection of DIO/DR phenotype
Male Sprague-Dawley rats (n ¼ 40, Charles River, L'Abresle, France) weighing 324 ± 1 g were housed individually in a temperature-controlled vivarium with a 12/12-h light/dark cycle and fed standard rodent chow (3.1 kcal g --1
; RM3A(P), SDS Diets, Witham, UK) for 1 week, after which they were switched to a HE/HF diet (D12266B, 4.2 kcal g --1 ; Research Diets, New Brunswick, NJ, USA). Following 3 weeks on the HE/HF diet, rats were selected for DIO and DR phenotypes as described elsewhere. 2 Briefly, rats were separated based on the weight gain, with the upper tertile (n ¼ 12) being designated 'DIO' and the lowest tertile (n ¼ 12) designated 'DR.' A total of 12 animals (n ¼ 6 DIO and n ¼ 6 DR) were selected from each group and used to test responses to nutrient-induced satiation. Daily food intake was measured for 5 consecutive days immediately before nutrient gavage experiments commenced. Throughout the experiments, food and water were provided ad libitum, except where noted otherwise. All experiments were approved by the animal ethics committee and carried out in accordance with the European Guidelines for the Care and Use of Laboratory Animals.
Reponses to gastric nutrient loads After 10 weeks of ad libitum HE/HF feeding, DIO and DR rats (n ¼ 6 per phenotype) with initial body weights of 705 ± 24 and 598 ± 19 g, respectively, were used to test feeding responses to IG nutrient loads. Nutrients were administered IG to mimic gastric and intestinal feedback following a typical meal, while bypassing responses from oral factors known to influence food intake. Before experimental protocol began and to achieve stable baselines, rats were acclimated to overnight food deprivation and IG gavages of 5-ml saline loads for three trials. On test days, food-deprived rats (1700 --0900 h) received 5 ml, 0.9% saline, or an isocaloric (10 kcal) 20% intralipid (IL), 50% glucose solution via oral gavage. The caloric load used was based on previous work. 30 At 5 min after gavage, rats were given preweighed amounts of pelleted HE/HF diet, and intake, accounting for spillage, was measured at 2 h post gavage. Experiments were conducted every other day, with each nutrient tested in separate blocks (IL followed by glucose) and each nutrient test bracketed by an IG saline load. Each nutrient was gavaged at least twice.
Tissue collection
A separate group of DIO and DR rats (n ¼ 5 for each phenotype) weighing 747±16 and 622±19 g, respectively, were used for collection of tissues. Briefly, animals were killed under deep anesthesia, and the proximal intestine comprising the duodenum and jejunum was excised, and epithelial cells were collected for RNA and protein expressions. Bilateral nodose ganglia were removed as previously described 31 and stored in AllProtect Tissue Reagent (Qiagen, Courtaboeuf, France) at 2 1C until RNA extraction.
Intestinal epithelium collection
Intestinal epithelial cells were collected using the everted sac method. Briefly, intestines were flushed with 10 ml ambient physiological saline followed by 10 ml oxygenated (95:5 O 2 /CO 2 ) Ca 2 þ and Mg 2 þ -free Krebs-Henseleit buffer. Intestines were then everted and incubated in oxygenated Ca 2 þ , Mg 2 þ -free Krebs-Henseleit buffer with EDTA and dithiothreitol for 20 min in 37 1C water bath. The suspension was collected, centrifuged and washed with Dulbecco's phosphate buffered-saline without Ca 2 þ or Mg 2 þ (Lonza France Sàrl, Levallois-Perret, France). Washing and centrifugation was repeated three times, after which Solution D (Sigma, Lyon, France) with b-mercaptoethanol (Sigma) was added to cell extract aliquots, and samples were snap frozen and stored at À80 1C until extraction.
Quantitative real-time PCR RNA was extracted from isolated epithelial cells using the phenol --chloroform method 32 or TRIzol (Invitrogen, Cergy-Pontoise, France) method, adjusted for 300 mg of tissue. Nodose ganglia tissue was lysed and homogenized with a TissueLyser (Qiagen) and RNA extracted using RNEasy Fibrous Tissue Mini-kits (Qiagen) according to the manufacturer's instructions. For complementary DNA (cDNA) synthesis, a total of 10 mg RNA from intestinal epithelial cells and 0.4 mg RNA from nodose ganglia was reverse transcribed in a reaction volume of 100 and 60 ml, respectively, using the high-capacity cDNA kit (Applied Biosystems, Courtaboeuf, France). Subsequently, cDNA was diluted fivefold for intestinal samples and 2.4-fold for nodose samples. Quantitative real-time PCR was performed in a reaction volume of 20 ml using ABI Prism 7700 thermal cycler (Applied Biosystems). Samples were run in triplicate, and transcription levels of CCK, GLP-1, PYY, GPR40, GPR41, GPR120, LepR and CCK-1R were quantified using inventoried Taqman Gene Expression Assays and Gene Expression Master Mix (Applied Biosystems). Relative mRNA expression was quantified using the 2 ÀDDCT method with b-actin as internal control.
Western blotting
Isolated intestinal epithelial cell aliquots were suspended in 1 ml of RIPA (Radio Immunoprecipitation Assay) buffer containing protease inhibitors (Sigma). After lysing and homogenizing the cells, samples were centrifuged for 20 min at 13 000 r.p.m. at 4 1C, and the supernatant was used to determine protein concentration (NanoDrop, Thermo Scientific, Illkirch, France). Soluble protein (100 mg) was run on sodium dodecyl sulfatepolyacrylamide gel electrophoresis gels containing 8--12% acrylamide, transferred to nitrocellulose membranes and probed with CCK, GLP-1, PYY, GPR40, GPR41 and GPR120 antibodies (diluted 1:250; Santa Cruz Biotechnology, Heidelberg, Germany). Immune complexes were detected by chemiluminescence (GE Healthcare, Saclay, France), and quantification was determined by scanning densitometry using ImageJ (NIH, Bethesda, MD, USA) against b-actin (diluted 1:1000; Santa Cruz Biotechnology) as internal control.
Statistical analyses
Data from IG nutrient test loads were computed with Statistical Analysis Software (SAS, version 9.1.3, Cary, NC, USA) and all other data were analyzed using GraphPad Prism 5 (GraphPad Software, La Jolla, CA, USA). Average body weights were analyzed by one-way (phenotype) repeated measures analysis of variance. The 24-h food intake was analyzed by oneway (phenotype) analysis of variance. For each IG nutrient load test, percent suppression of food intake from baseline for each rat was calculated and analyzed by two-way (phenotype, treatment) repeated
Intestinal nutrient sensitivity and obesity FA Duca et al measures analysis of variance with post hoc Bonferroni adjustment. Percent suppression of baseline food intake was calculated for each individual rat for each test by the formula: % Suppression ¼ 1À(treatment/baseline) Â 100. Values from quantitative real-time PCR were analyzed using Student's t-tests. Independent western blots were pooled and data expressed as percent change from DR rats, and analyzed using Student's t-tests. Values are reported throughout the text as means ± s.e.m. Significance was considered at ao0.05 for all tests.
RESULTS
Body weights and 24-h food intake After 4 weeks of HE/HF ad libitum feeding, DIO rats weighed significantly more than DR rats (DIO: 563±6 g; DR: 500±10 g, Po0.001), and this persisted until the end of the experiment (DIO: 696 ± 23 g; DR: 611 ± 30 g, Po0.05; Figure 1a ). Also, DIO consumed significantly more calories over 24-h compared with DR rats (Po0.05; Figure 1b ). Nutrient-responsive receptor expression Gene as well as protein expressions of the three GPRs isolated from the intestinal epithelium were significantly increased in DIO compared with DR rats: GPR40 mRNA (Po0.001; Figure 4a ) and protein expression (Po0.0001; Figure 4b ); GPR41 mRNA (Po0.01; Figure 4c ) and protein expression (Po0.001; Figure 4d) ; and GPR120 mRNA (Po0.0001; Figure 4e ) and protein expression (Po0.01; Figure 4f ).
Anorectic receptor expression in nodose ganglia
In the nodose ganglia, DIO and DR rats exhibited similar levels of expression for CCK-1R mRNA, whereas LepR mRNA expression was slightly increased in DIO rats relative to DR, a trend that did not reach statistical significance (P ¼ 0.12; Figure 5 ).
DISCUSSION
In the present study, we found that DIO rats displayed reduced suppression of subsequent energy intake in response to IG IL, but not glucose, compared with DR rats. Furthermore, this reduced intestinal nutrient response to IL in DIO rats was associated with decreases in intestinal gene and protein expressions of CCK, PYY and GLP-1. Additionally, DIO rats also expressed increased GPR40, GPR41 and GPR120 gene and protein expressions relative to DR animals. Finally, there were no significant differences in gene expression for either CCK-1R or LepR between DIO and DR phenotypes. Non-obese and obese rats feeding a HF diet are less sensitive to the suppressive effects of intraintestinal nutrients and express an increased appetite for fat. 7, 30, 33 Similarly, genetically obese rats suppress feeding less in response to post-oral feedback elicited by nutrients. 30 Our current results extend these findings and demonstrate that DIO rats fed a HE/HF diet are also less responsive to the suppressive effects of GI fat. This could be partly due to decreased response to endogenous intestinal satiation, because PYY transcript levels were increased in DIO rats, whereas protein levels were decreased relative to DR rats. (e, f ) GLP-1 mRNA was similar in both DIO and DR rats, and protein expression of GLP-1 was decreased in DIO rats relative to DR animals. Data are expressed as means±s.e.m.; *Po0.05, **Po0.01 relative to DR rats. intestinal satiety peptide antagonists inhibit nutrient-induced satiation. 34 Indeed, our current results of decreased intestinal satiety peptides in DIO rats relative to DR rats show that decreased endogenous gut peptide signaling may be responsible for the decreased sensitivity to fat-induced satiation in DIO rats. This observation, coupled with the fact that DIO rats are more responsive to CCK 19, 35 but not to nutrient loads, suggests that they may not secrete as much CCK in response to fat. Although we have not measured stimulated and basal plasma levels of CCK, it is possible that increased CCK sensitivity observed in DIO rats is secondary to responses to GI nutrients. In addition, reported deficits in central signaling cascades, involving disrupted hypothalamic neural leptin projections and increased efficiency of the melanocortin system, resulting in failure to effectively integrate peripheral satiety signals, may also contribute to increased responsiveness to CCK in DIO rats, as we previously discussed elsewhere. 19 The GI nutrients induce satiation by engaging both gastric and intestinal inhibitory feedback signals (for review, see Ritter 36 ). In our study, nutrient loads were administered IG and intake measured 2 h post gavage. Thus, deficits in inhibitory signals arising from stomach as well as intestine could be responsible for short-term hyperphagia in DIO rats following nutrient gavages. In a previous study, HE/HF-fed DIO rats exhibited decreased 30-min gastric emptying, which suggest that they might be more sensitive to the inhibition of food intake by gastric loads. 37 However, this study assessed only emptying of a small (1.5 ml) methylcellulose load solution. Gastric emptying of nutrient loads in DIO rats has not been examined. Thus, we cannot speculate on the kinetics of peptide release as a function of gastric emptying in these animals. In principle, with few exceptions, 16 ,17 most studies demonstrate a decrease in CCK, GLP-1 and PYY in obese individuals following a test meal. 12, 14, 15 Therefore, it is likely that deficits in intestinal, rather than gastric, inhibitory signaling involving peptide expression or nutrient detection are responsible for hyperphagia in this model. Intestinal peptides are largely responsible for inducing satiation, and defects in their signaling pathways may contribute to obesity (for review, see Neary and Batterham 38 ). In our current study, intestinal protein content of CCK, PYY and GLP-1 was decreased in DIO relative to DR rats, which was associated with a decreased intestinal response to IL that may contribute to short-term hyperphagia following gastric nutrient loads. Whereas we measured peptide levels from the proximal intestine comprising the duodenum and jejunum, which are major sites of CCK secretion, GLP-1 and PYY are predominantly secreted in the distal intestine. However, studies examining peptide content of GLP-1 (ref. 39) and PYY 40 show that both peptides are present throughout the intestine. Additionally, the duodenum contains a significant number of L cells capable of secreting considerable GLP-1 and PYY in response to nutrients. 41 Previous findings that DIO rats are more responsive to CCK, 19, 35 along with our current data demonstrating a decreased response to IL and decreased intestinal expression of CCK, may suggest that DIO rats secrete less CCK in response to fats. Furthermore, GLP-1 signaling is disrupted in obese rats fed a HF diet compared with low-fat-fed animals, which may also contribute to decreased responsiveness to intestinal fats. 11 Thus, attenuated intestinal secretory responses and disrupted satiation signaling may account for the differences in reduction of food intake by IL observed between DIO and DR rats.
Impaired sensitivity to insulin has also been implicated as a factor in hyperphagia in DIO models. Consumption of a HF diet promotes development of insulin resistance. 42 Both CCK and GLP-1 enhance insulin secretion and facilitate glucose tolerance, with insulin resistance being associated with attenuated GLP-1 response. 43 PYY has also been linked to obesity and insulin resistance. 44 Although we have not measured insulin resistance in our studies, it is plausible that alterations in secretion, expression and/or action of gut peptides, particularly incretins, may have been because of the development of obesity and insulin resistance in DIO rats. In addition to our findings demonstrating a decreased response to intestinal fat, we also found that DIO rats suppressed caloric intake less, although nonsignificant, compared with DR rats after a glucose load, similar to previous data in genetically obese rats. 30 Our observation of decreased intestinal peptide expression would suggest decreased glucose responsiveness in this model. For example, antagonism of GLP-1R or CCK-1R reverses carbohydrate-induced satiation, 45, 46 whereas glucose induces both GLP-1 and PYY release. Despite decreased intestinal peptide content, we have also observed increased GLUT2 protein levels in DIO compared with DR rats (M Covasa, unpublished observations), which would enhance glucose uptake from the intestine and possibly increase responsiveness to glucose-induced satiation. Thus, despite decreased intestinal satiety peptide content, increased glucose transporters in DIO rats may mask the difference in the response of DIO rats after glucose load. Finally, our results demonstrating decreased intestinal satiety peptide expression are consistent with previous findings demonstrating decreases in plasma GLP-1, 15 PYY 12 and CCK 14 in obese or morbidly obese individuals relative to lean subjects. Although we did not measure circulating plasma peptides, expression of intestinal peptides normally correlates with plasma levels. 47 Located on the luminal apical portion of enteroendocrine cells, intestinal GPRs mediate nutrient-induced satiety peptide secretion. Stimulation of fatty acid-responsive GPRs results in peptide release, 21 whereas knockout of intestinal GPRs decreases plasma satiety peptides, 20 and leads to increased food intake and body weight. 23 Specifically, GPR41 is involved in PYY secretion, 22 whereas GPR40 and GPR120 are possible nutrient detectors mediating CCK and GLP-1 secretion. 20, 21, 24 Although evidence of the functional role of nutrient receptors in mediating peptide release is still emerging, no studies have examined how diet and obesity may affect nutrient sensing in the small intestine. We found that gene expression of GPR40, GPR41 and GPR120 was upregulated in DIO rats relative to DR rats. Furthermore, DIO rats had an increased abundance of GPR40, GPR41 and GPR120 protein relative to DR rats. Together, these data suggest that HE/HF feeding in the DIO model results in increased expression of fatty acid-responsive receptors in the proximal intestine, a major site for nutrient detection, absorption and satiety peptide release. There are several plausible explanations for our results demonstrating general increased fatty acid-responsive GPRs, yet decreased intestinal peptide expression. Previous studies have found that obesity is correlated with satiety peptide receptor gene polymorphisms. 48 Therefore, it is possible that altered encoding for GPRs in DIO animals may result in decreased nutrient-binding affinities, leading to a compensatory increase in GPR expression, which may be further affected by the diet. Furthermore, intracellular cascades or further downstream pathways, such as post-transcriptional modifications, may contribute to deficits between nutrient-responsive GPR signaling and peptide production, leading to upregulation of luminal GPRs in order to increase satiety peptide release. Despite this, evidence involving pathways of events leading from GPR stimulation to peptide expression and secretion is scant.
Vagal pathways are important conduits for mediating the actions of satiety peptides. For example, CCK predominantly acts through vagal afferents to induce satiation. Feeding a HF diet in rodents results in increased CCK secretion and decreased sensitivity to CCK, which may be through downregulation of the CCK-1R, a GPR that is normally downregulated from overstimulation (for review, see Covasa 49 ). Despite differences in intestinal CCK expression in DIO and DR rats, we found no overall changes in CCK-1R expression in the nodose ganglia between phenotypes. Although this study does not allow the effect of obesity versus HF feeding to be distinguished, previous findings examining CCK-1R expression in the nodose ganglia are conflicting. In one study, CCK-1R mRNA was upregulated in the nodose ganglia of DIO rats; 50 however, in obese mice, HF feeding was associated with downregulation of CCK-1R mRNA expression 27 and had no effect on non-obese rats. 51 The differences observed in these studies may be because of the differences in the diet fed, model used or duration of HF feeding. Similarly, LepR mRNA expression was similar between DIO and DR animals, in agreement with previous data. 50 Strictly based on our current findings, it appears that vagal CCK-1R and LepR levels do not play a major role in animals susceptible to obesity. However, despite similar CCK-1R and LepR transcript levels in DIO and DR rats, we cannot exclude differences in receptor function between the two strains. For example, protein expression of CCK-1R and LepR may be different between DIO and DR rats because of post-transcriptional modifications. Furthermore, receptor-binding affinities that are normally associated with genetic polymorphisms may also differ between DIO and DR animals. Finally, immunohistochemical and electrophysiological studies have shown that HF-fed DIO mice exhibit decreased vagal responsiveness to exogenous CCK. 52 Although abnormalities in peripheral and central CCK-1R and LepR deficits result in obesity, 53, 54 the relative contribution of vagal CCK-1R and LepR signaling to obesity is still emerging. It is well established that CCK and leptin interact synergistically at several levels including activation of vagal afferent neurons, 55 and co-administration of both peptides results in decreased food intake and body weight. 56 It is noteworthy that DIO rats display leptin resistance in the vagal afferents, which is independent of LepR levels and occurs before the onset of leptin resistance in the arcuate nucleus, a key regulator of energy homeostasis. 57 Therefore, despite similar vagal CCK-1R and LepR transcripts between DIO and DR rats, DIO models display decreased vagal sensitivity, which would further impair endogenous satiation signaling leading to decreased responsiveness to fat-induced satiation.
Together, the results of our studies demonstrate that outbred DIO rats exhibit reduced responsiveness to GI fat when fed a HE/HF diet. This decreased response is associated with marked reduction in intestinal CCK, PYY and GLP-1 protein abundance, and increases in intestinal GPR40 and GPR120 protein expression. Finally, despite differences in nutrient-load responses and intestinal satiety peptide expression, there are no changes in nodose ganglia expression of CCK-1R and LepR between DIO and DR animals. We conclude that development of DIO may be partly a consequence of decreased nutrient-induced satiation through low levels of endogenous intestinal satiety peptides and increased intestinal nutrient receptors, resulting in short-term hyperphagia. Furthermore, the development of DIO appears to be independent of CCK-1R and LepR mRNA transcript in vagal afferents, but may involve impaired signaling through alterations in vagal receptor functions.
